ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT

This adverse event was reported 11 times

ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI 6 0.0779
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL 2 0.0022
2 IDURSULFASE 1 0.0003
3 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1 0.0001
4 ESOMEPRAZOLE MAGNESIUM 1 0.0000
See all drugs enriched for association with ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT

These drug classes are most commonly taken by patients reporting ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT:

# Drug class Count
0 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
See all common drug classes associated with ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT

ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
See all drug classes enriched for association with ANTI-POLYETHYLENE GLYCOL ANTIBODY PRESENT